CorMedix (CRMD) - P/S ratio

P/S ratio as of September 2026 (TTM): 1.54

According to CorMedix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.41. At the end of 2026 the company had a P/S ratio of 1.33.

P/S ratio history for CorMedix from 2010 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	1.33	-56.86%
2025	3.07	-73.18%
2024	11.5
2023	N/A	-100%
2022	> 1000	193.46%
2021	908	-9.06%
2020	998	51.3%
2019	660	101.85%
2018	327	219.85%
2017	102	-62.98%
2016	276	-20.56%
2015	347	53.28%
2014	227	-97.8%
2013	> 1000
2012	N/A
2011	N/A
2010	N/A

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Becton Dickinson BDX	2.33	51.69%	🇺🇸 USA
Utah Medical Products UTMD	5.99	289.98%	🇺🇸 USA
Emergent BioSolutions EBS	0.5065	-67.05%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for CorMedix (CRMD)

P/S ratio as of September 2026 (TTM): 1.54